November 1, 2003Open Access

Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from Newborns

Key Points

Key points are not available for this paper at this time.

Abstract

Multianalyte technologies such as MS/MS are suitable for newborn screening and other mass screening programs because they improve the detection of many diseases in the current screening panel while enabling expansion to disorders that are now recognized as important and need to be identified in pediatric medicine.

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Chace et al. (Sat,) studied this question.

synapsesocial.com/papers/69d90192537c710c9cae2cb7 https://doi.org/https://doi.org/10.1373/clinchem.2003.022178

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Vaccinia (Smallpox) Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 20012001 · 1,021 citations
2Propionylcarnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency1984 · 90 citations
3Newborn Screening for Maple Syrup Urine Disease (Branched-Chain Ketoaciduria)1978 · 63 citations
4Dietary supplements for the lactating mother: influence on the trace element content of milk1999 · 63 citations
5Analysis of Mitochondrial Fatty Acid Oxidation Intermediates by Tandem Mass Spectrometry from Intact Mitochondria Prepared from Homogenates of Cultured Fibroblasts, Skeletal Muscle Cells, and Fresh Muscle2002 · 20 citations

Perguntar à IA

Bookmark

View Full Paper